InsidersTradesSigma
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
10
Disclosed sells
2
T+90 hit rate
18%
T+90 mean return
-22.4%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by KIRK RANDAL J, Director. Insider active across 5 companies, notably Precigen, INC.. Cumulatively, 37 filings have been logged. Breakdown: 10 buys · 2 sells. Total volume traded: €56.7m. History available since 19 November 2021. The latest transaction was disclosed on 13 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations37 total
57,471 shares@ US$1.740.2% of flowCommon StockSEC:0001213900-25-024643:0
23,529,411 shares@ US$0.8546.6% of flowCommon StockSEC:0001213900-24-068267:0
Ideal exit: 6 May 2025 (T+270)
58,800 shares0Common StockSEC:0001213900-24-039855:0
69,930 shares@ US$1.430.2% of flowCommon StockSEC:0001213900-24-023626:0
213,675 shares0Common StockSEC:0001213900-24-021905:0
96,686 shares@ US$1.410.3% of flowCommon StockSEC:0001213900-23-100214:0
Ideal exit: 23 Sept 2024 (T+270)
100,000 shares@ US$1.500.3% of flowCommon StockSEC:0001140361-23-040174:0
Ideal exit: 11 May 2024 (T+270)
85,470 shares@ US$1.170.2% of flowCommon StockSEC:0001567619-23-004946:0
123,152 shares0Common StockSEC:0001567619-23-003795:0
11,428,571 shares@ US$1.7546.7% of flowCommon StockSEC:0001567619-23-001546:0
Ideal exit: 24 Oct 2023 (T+270)
3,443 sharesCommon StockSEC:0001567619-23-000629:0
660,091 sharesCommon StockSEC:0001567619-22-018363:0
32,425 shares0Common StockSEC:0001567619-22-007614:0
49,261 shares@ US$2.030.0056% mcap4.2% of flowCommon StockSEC:0001567619-22-005526:0
3,444 sharesCommon StockSEC:0001567619-22-000657
3,444 sharesCommon StockSEC:0001567619-22-000657:0
4,742,552 shares@ US$2.1050.0% of flowCommon StockSEC:0001567619-21-021154:0
4,742,552 shares@ US$2.1050.0% of flowCommon StockSEC:0001567619-21-021154
307,661 shares@ US$3.750.064% mcap47.9% of flowCommon StockSEC:0001567619-21-021122:0
Ideal exit: 16 Aug 2022 (T+270)
307,661 shares@ US$3.752.6% of flowCommon StockSEC:0001567619-21-021122
Ideal exit: 16 Aug 2022 (T+270)
53,571 sharesCommon StockSEC:0001567619-21-017572:0
53,571 sharesCommon StockSEC:0001567619-21-017572
354,557 sharesCommon StockSEC:0001567619-21-011765
354,557 sharesCommon StockSEC:0001567619-21-011765:0
6,863 sharesCommon StockSEC:0001140361-16-049714:0
25 of 37 declarations
About KIRK RANDAL J
Randal J. Kirk is a Director at Precigen, Inc. and AquaBounty Technologies, Inc. In this role, he brings his expertise in governance and corporate strategy. His experience in the biopharmaceutical sector allows him to effectively contribute to strategic decisions and the direction of these companies.
